Grants and Contributions:
Agreement Number:
-
Agreement Value:
$573,786.00
Agreement Date:
Oct 1, 2013 - Sep 30, 2016
Description:
Randomized controlled trial of the efficacy of pre-emptive tenofovir to prevent hepatitis B reactivation in patients who are anti-HBc antibody positive receiving curative intent rituximab-based chemotherapy for non-Hodgkin's lympohma
Organization:
Canadian Institutes of Health Research
Location:
Toronto, Ontario, CA M5G 2C4
Reference Number:
236-2013-2014-Q1-00122
Agreement Type:
Grant
Report Type:
Grants and Contributions
Additional Information:
Grant or Award spanning more than one fiscal year.
(2013-14 to 2016-17)
Recipient's Legal Name:
FELD, Jordan J
Research Organization:
University Health Network (Toronto)